Basic residues of human group IIA phospholipase A2 are important for binding to factor Xa and prothrombinase inhibition comparison with other mammalian secreted phospholipases A2.
Mounier, C. M.; Luchetta, P.; Lecut, Christelleet al.
2000 • In European Journal of Biochemistry, 267 (16), p. 4960-9
[en] Human secreted group IIA phospholipase A2 (hGIIA) was reported to inhibit prothrombinase activity because of binding to factor Xa. This study further shows that hGIIA and its catalytically inactive H48Q mutant prolong the lag time of thrombin generation in human platelet-rich plasma with similar efficiency, indicating that hGIIA exerts an anticoagulant effect independently of phospholipid hydrolysis under ex vivo conditions. Charge reversal of basic residues on the interfacial binding surface (IBS) of hGIIA leads to decreased ability to inhibit prothrombinase activity, which correlates with a reduced affinity for factor Xa, as determined by surface plasmon resonance. Mutation of other surface-exposed basic residues, hydrophobic residues on the IBS, and His48, does not affect the ability of hGIIA to inhibit prothrombinase activity and bind to factor Xa. Other basic, but not neutral or acidic, mammalian secreted phospholipases A2 (sPLA2s) exert a phospholipid-independent inhibitory effect on prothrombinase activity, suggesting that these basic sPLA2s also bind to factor Xa. In conclusion, this study demonstrates that the anticoagulant effect of hGIIA is independent of phospholipid hydrolysis and is based on its interaction with factor Xa, leading to prothrombinase inhibition, even under ex vivo conditions. This study also shows that such an interaction involves basic residues located on the IBS of hGIIA, and suggests that other basic mammalian sPLA2s may also inhibit blood coagulation by a similar mechanism to that described for hGIIA.
Basic residues of human group IIA phospholipase A2 are important for binding to factor Xa and prothrombinase inhibition comparison with other mammalian secreted phospholipases A2.
Davidson F.F., Dennis E.A. (1990) Evolutionary relationships and implications for the regulation of phospholipase A2 from snake venom to human secreted forms. J. Mol. Evol. 31:228-238.
Dennis E.A. (1997) The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem. Sci. 22:1-2.
Tischfield J.A. (1997) A reassessment of the low molecular weight phospholipase A2 gene family in mammals. J. Biol. Chem. 272:17247-17250.
Lambeau G., Lazdunski M. (1999) Receptors for a growing family of secreted phospholipases A2. Trends Pharmacol. Sci. 20:162-170.
Valentin E., Koduri R.S., Scimeca J.-C., Carle G., Gelb M.H., Lazdunski M., Lambeau G. (1999) Cloning and recombinant expression of a novel mouse-secreted phospholipase A2. J. Biol. Chem. 274:19152-19160.
Ishizaki J., Suzuki N., Higashino K., Yokota Y., Ono T., Kawamoto K., Fujii N., Arita H., Hanasaki K. (1999) Cloning and characterization of novel mouse and human secretory phospholipase A2s. J. Biol. Chem. 274:24973-24979.
Valentin E., Ghomashchi F., Gelb M.H., Lazdunski M., Lambeau G. (1999) On the diversity of secreted phospholipases A2. J. Biol. Chem. 274:31195-31202.
Murakami M., Nakatani Y., Atsumi G., Inoue K., Kudo I. (1997) Regulatory functions of phospholipase A2. Crit Rev. Immunol. 17:225-283.
Glaser K.B., Mobilio D., Chang J.Y., Senko N. (1993) Phospholipase A2 enzymes: Regulation and inhibition. Trends Pharmacol. Sci. 14:92-98.
Pruzanski W., Vadas P., Browning J. (1993) Secretory nonpancreatic group II phospholipase A2: Role in physiologic and inflammatory processes. J. Lipid Med. 8:161-167.
Elsbach P., Weiss J. (1993) Bactericidal/permeability increasing protein and host defense against gram-negative bacteria and endotoxin. Curr. Opin. Immunol. 5:103-107.
White S.R., Strek M.E., Kulp G.V.P., Spaethe S.M., Burch R.A., Neeley S.P., Leff A.R. (1993) Regulation of human eosinophil degranulation and activation by endogenous phospholipase A2. J. Clin. Invest. 91:2118-2125.
Murakami M., Hara N., Kudo I., Inoue K. (1993) Triggering of degranulation in mast cells by exogenous type-II phospholipase A2. J. Immunol. 151:5674-5684.
Kurihara H., Nakano T., Takasu N., Arita H. (1991) Intracellular localization of group-II phospholipase-A2 in rat vascular smooth muscle cells and its possible relationship to eicosanoid formation. Biochim. Biophys. Acta 1082:285-292.
Suga H., Murakami M., Kudo I., Inoue K. (1993) Participation in cellular prostaglandin synthesis of type-II phospholipase A2 secreted and anchored on cell-surface heparan sulfate proteoglycan. Eur. J. Biochem. 218:807-813.
Horigome K., Hayakawa M., Inoue K., Nojima S. (1987) Selective release of phospholipase A2 and lysophosphatidylserine-specific lysophospholipase from rat platelets. J. Biochem. , Tokyo; 101:53-61.
Kramer R.M., Hession C., Johansen B., Hayes G., McGray P., Chow E.P., Tizard R., Pepinsky R.B. (1989) Structure and properties of a human non-pancreatic phospholipase A2. J. Biol. Chem. 264:5768-5775.
Mounier C., Faili A., Vargaftig B.B., Bon C., Hatmi M. (1993) Secretory phospholipase A2 is not required for arachidonic acid liberation during platelet activation. Eur. J. Biochem. 216:169-175.
Mounier C., Vargaftig B.B., Franken P.A., Verheij H.M., Bon C., Touqui L. (1994) Platelet secretory phospholipase A2 fails to induce rabbit platelet activation and to release arachidonic acid in contrast with venom phospholipases A2. Biochim. Biophys. Acta 1214:88-96.
Kramer R.M., Roberts E.F., Manetta J.V., Hyslop P.A., Jakubowski J.A. (1993) Thrombin-induced phosphorylation and activation of Ca2+-sensitive cytosolic phospholipase-A2 in human platelets. J. Biol. Chem. 268:26796-26804.
Cirino G., Cicala C., Sorrentino L., Browning J.L. (1993) Human recombinant non pancreatic secreted platelet phospholipase A2 has anticoagulant activity in vitro on human plasma. Thromb. Res. 70:337-342.
Mounier C., Franken P.A., Verheij H.M., Bon C. (1996) The anticoagulant effect of the human secretory phospholipase A2 on blood plasma and on a cell-free system is due to a phospholipid-independent mechanism of action involving the inhibition of factor Va. Eur. J. Biochem. 237:778-785.
Inada M., Crowl R.M., Bekkers A., Verheij H., Weiss J. (1994) Determinants of the inhibitory action of purified 14-kDa phospholipases A2 on cell-free prothrombinase complex. J. Biol. Chem. 269:26338-26343.
Mann K.G., Nesheim M.E., Church W.R., Haley P., Krishnaswamy S. (1990) Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 76:1-16.
Zwaal R.F.A., Comfurius P., Bevers E.M. (1992) Platelet procoagulant activity and microvesicle formation: Its putative role in hemostasis and thrombosis. Biochim. Biophys. Acta 1180:1-8.
Davie E.W. (1995) Biochemical and molecular aspects of the coagulation cascade. Thromb. Haemost. 74:1-6.
Tracy P.B., Eide L.L., Bowie E.J.W., Mann K.G. (1982) Radioimmunoassay of factor V in human plasma and platelets. Blood 60:59-63.
Rosing J., Speijer H., Zwaal R.F.A. (1988) Prothrombin activation on phospholipid membranes with positive electrostatic potential. Biochemistry 27:8-11.
Mounier C., Hackeng T.M., Schaeffer C., Faure G., Bon C., Griffin J.H. (1998) Inhibition of prothrombinase by human secretory phospholipase A2 involves binding to factor Xa. J. Biol. Chem. 273:23764-23772.
Ouyang C., Teng C.M., Huang T.E. (1992) Characterization of snake venom components acting on blood coagulation and platelet function. Toxicon 30:945-966.
Kini R.M., Evans H.J. (1989) A model to explain the pharmacological effects of snake venom phospholipases A2. Toxicon 27:613-635.
Verheij H.M., Boffa M.C., Rothen C., Bryckaert M.C., Verger R., De Haas G.H. (1980) Correlation of enzymatic activity and anticoagulant properties of phospholipase A2. Eur. J. Biochem. 112:25-32.
Kini R.M., Evans H.J. (1987) Structure-function relationships of phospholipases. J. Biol. Chem. 262:14402-14407.
Snitko Y., Koduri R.S., Han S.K., Othman R., Baker S.F., Molini B.J., Wilton D.C., Gelb M.H., Cho W. (1997) Mapping the interfacial binding surface of human secretory group IIa phospholipase A2. Biochemistry 36:14325-14333.
Bezzine S., Koduri R.S., Valentin E., Murakami M., Kudo I., Ghomashchi F., Sadilek M., Lambeau G., Gelb M.H. (2000) Exogenously added human group X secreted phospholipase A2 but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells. J. Biol. Chem. 275:3179-3191.
Diaz C., Lomonte B., Zamudio F., Gutierrez J.M. (1995) Purification and characterization of myotoxin IV, a phospholipase A2 variant, from Bothrops asper snake venom. Natural Toxins 3:26-31.
Studies F.W., Moffat B.A. (1986) Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J. Mol. Biol. 189:113-130.
Franken P.A., Van den Berg L., Huang J., Gunyuzlu P., Lugtigheid R.B., Verheij H.M., De Haas G.H. (1992) Purification and characterization of a mutant human platelet phospholipase A2 expressed in Escherichia coli. Cleavage of a fusion protein with cyanogen bromide. Eur. J. Biochem. 203:89-98.
Koduri R.S., Baker S.F., Snitko Y., Han S.K., Cho W., Wilton D.C., Gelb M.H. (1998) Action of human group IIa secreted phospholipase A2 on cell membranes. Vesicles but not heparinoid binding determines rate of fatty acid release by exogenously added enzyme. J. Biol. Chem. 273:32142-32153.
Hemker H.C., Willems G.M., Beguin S. (1986) A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb. Haemost. 56:9-17.
Wielders S., Mukherjee M., Michiels J., Rijkers D.T.S., Cambus J.P., Knebel R.W.C., Kaddar V., Hemker H.C., Beguin S. (1997) The routine determination of the endogenous thrombin potential, first results in different forms of hyper and hypocoagulability. Thromb. Haemost. 77:629-636.
De Kruijff B., Cullis P.R., Radda G.K. (1975) Differential scanning calorimetry and 31P NMR studies on sonicated and unsonicated phosphattidylcholine liposomes. Biochim. Biophys. Acta 406:6-20.
Nieba L., Krebber A., Pluckhun A. (1996) Competition BIAcore for measuring true affinities: Large differences from values determined from binding kinetics. Anal. Biochem. 234:155-165.
Sunnerhagen M., Forsen S., Hoffren A.-M., Drakenberg T., Stenflo J. (1995) Structure of the Ca++-free GLA domain sheds light on membrane binding of blood coagulation proteins. Nat. Struct. Biol. 2:504-509.
Renetseder R., Brunie S., Dijkstra B.V., Drenth J., Sigler P.B. (1985) A comparison of the crystal structures of phospholipase A2 from bovine pancreas and Crotalus atrox venom. J. Biol. Chem. 260:11627-11634.
Baker S.F., Othman R., Wilton D.C. (1998) Tryptophan-containing mutant of human (group IIa) secreted phospholipase A2 has a dramatically increased ability to hydrolyze phosphatidylcholine vesicles and cell membranes. Biochemistry 37:13203-13211.
Seilhamer J.J., Randall T.L., Yamanaka M., Johnson L.K. (1986) Pancreatic phospholipase A2: Isolation of the human gene and cDNAs from porcine pancreas and human lung. DNA 5:519-527.
Seilhamer J.J., Pruzanski W., Vadas P., Plant S., Miller J.A., Kloss J., Johnson L.K. (1989) Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid. J. Biol. Chem. 264:5335-5338.
Ishizaki J., Ohara O., Nakamura E., Tamaki M., Ono T., Kanda A., Yoshida N., Teraoka M., Tojo H., Okamoto M. (1989) cDNA cloning and sequence determination of rat membrane-associated phospholipase A2. Biochem. Biophys. Res. Commun. 162:1030-1036.
Kadam S., Deshpande C., Coulier F., Mulherkar R. (1998) Sequence analysis of full length cDNA for enhancing factor/phospholipase A2. Indian J. Exp. Biol. 36:553-558.
Chen J., Engle S.J., Seilhamer J.J., Tischfield J.A. (1994) Cloning and recombinant expression of a novel human low molecular weight Ca++-dependent phospholipase A2. J. Biol. Chem. 269:2365-2368.
Chen J., Engle S.J., Seilhamer J.J., Tischfield J.A. (1994) Cloning, expression and partial characterization of a novel rat phospholipase A2. Biochim. Biophys. Acta 1215:115-120.
Cupillard L., Koumanov K., Mattei M.G., Lazdunski M., Lambeau G. (1997) Cloning, chromosomal mapping, and expression of a novel human secretory phospholipase A2. J. Biol. Chem. 272:15745-15752.
Wyman J., Stanley J., Binding and Linkage. University Science Books; 1990.
Beguin S., Keularts I. (1999) On the coagulation of platelet-rich plasma. Haemostasis 29:50-57.
Kessels H., Beguin S., Andree H., Hemker H.C. (1994) Measurement of thrombin generation in whole blood. The effect of heparin and aspirin. Thromb. Haemost. 72:78-83.
Beguin S., Lindhout T., Hemker H.C. (1989) The effect of trace amounts of tissue factor on thrombin generation in platelet-rich plasma, its inhibition by heparin. Thromb. Haemost. 61:25-29.
Fourcade O., Simon M.-F., Viode C., Rugani N., Leballe F., Ragab A., Fournie B., Sarda L., Chap H. (1995) Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 80:919-927.
Murakami M., Kudo I., Inoue K. (1993) Molecular nature of phospholipase A2 involved in prostaglandin I2 synthesis in human umbilical vein endothelial cells. Possible participation of cytosolic and extracellular type II phospholipases A2. J. Biol. Chem. 268:839-845.
Vadas P., Browning J., Edelson J., Pruzanski W.J. (1993) Extracellular phospholipase A2 expression and inflammation: The relationship with associated disease states. J. Lipid Med. 8:1-30.
Kaizer E. (1999) Phospholipase A2: Its usefulness in laboratory diagnostics. Crit. Rev. Clin. Lab. Sci. 36:65-163.
Emadi S., Mirshahi M., Elalamy I., Nicolas C., Vargaftig B.B., Hatmi M. (1998) Cellular source of human platelet secretory phospholipase A2. Br. J. Haematol. 100:365-373.
Pruzanski W., Scott K., Smith G., Rajkovic I., Stefanski E., Vadas P. (1992) Enzymatic activity and immunoreactivity of extracellular phospholipase A2 in inflammatory synovial fluids. Inflammation 16:451-457.
Kortesuo P.T., Nevalainen T.J. (1991) Phospholipase A2 in human ascitic fluid. Purification, characterization and immunochemical detection. Biochem. J. 278:263-267.
Nevalainen T.J., Meri K.M., Niemi M. (1993) Synovial-type (group II) phospholipase A2 in human seminal plasma. Andrologia 25:355-358.
Qu X.D., Lehrer R.I. (1998) Secretory phospholipase A2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears. Infect. Immun. 66:2791-2797.
Ouyang C., Teng C.M., Chen Y.C., Lin S.C. (1978) Purification and characterization of the anticoagulant principle of Trimeresurus mucrosquamatus venom. Biochim. Biophys. Acta 541:394-407.
Stefansson S., Kini R.M., Evans H.J. (1990) The basic phospholipase A2 from Naja nigricollis venom inhibits the prothrombinase complex by a novel nonenzymatic mechanism. Biochemistry 29:7742-7746.
Babu A.S., Gowda T.V. (1994) Dissociation of enzymatic activity from toxic properties of the most basic phospholipase A2 from Vipera russelli snake venom by guanidination of lysine residues. Toxicon 32:749-752.
Kerns R.T., Kini R.M., Stefansson S., Evans H. (1999) Targeting of venom phospholipases: The strongly anticoagulant phospholipase A2 from Naja nigricollis venom binds to coagulation factor Xa to inhibit the prothrombinase complex. Arch. Biochem. Biophys. 369:107-113.
